Dr. Puppo and Dr. Casarico, from Italy, will be presenting their outstanding results of Renova treatment for Vascular Erectile Dysfunction focusing on long term effects of up to 20 months follow-up. "At 6 months, FU showed overall success in 79% of the patients, that was maintained by 78.5% of these at longer FU (19.8 months mean). 55% of PDE5i responders (at baseline evaluation) continued to have successful intercourse without use of PDE5i or using them occasionally." Presentation will take place at the upcoming Italian Urological Association Congress (Auro.it National Congress), which will be held in Bologna, May 24-26. Dr Casarico's presentation will transpire on May 24, at 15:30.
About DirexGroup:
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established nearly 30 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assure competent support and maintenance. Contact DirexGroup at: This email address is being protected from spambots. You need JavaScript enabled to view it.
